Valion Bio, Inc. Cash Equivalents, at Carrying Value
Valion Bio, Inc. (VBIO) had Cash Equivalents, at Carrying Value of $2.20 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash Equivalents, at Carrying Value $2.20M.
- 2026-03-31: Cash Equivalents, at Carrying Value $6.70M.
- 2025-12-31: Cash Equivalents, at Carrying Value $12.20M.
- 2025-09-30: Cash Equivalents, at Carrying Value $2.80M.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $2.20M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $6.70M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $12.20M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $2.80M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $975.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $417.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.80M 10-K · filed 2026-03-30 | $1.82M 10-K · filed 2025-03-21 |
| 2024-09-30 | $2.14M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $3.24M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.24M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $3.24M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $4.74M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.17M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $4.99M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $3.07M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $6.00M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $8.74M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $10.34M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $12.79M 10-K · filed 2023-03-31 | $12.80M 10-Q · filed 2022-05-16 |
| 2021-03-31 | $12.79M 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |